Bellevue Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $409M | Sell |
|
|||||
|
2025
Q2 | $310M | Hold |
|
|||||
|
2025
Q1 | $237M | Sell |
|
|||||
|
2024
Q4 | $275M | Sell |
|
|||||
|
2024
Q3 | $315M | Sell |
|
|||||
|
2024
Q2 | $394M | Sell |
|
|||||
|
2024
Q1 | $360M | Sell |
|
|||||
|
2023
Q4 | $441M | Sell |
|
|||||
|
2023
Q3 | $419M | Sell |
|
|||||
|
2023
Q2 | $385M | Sell |
|
|||||
|
2023
Q1 | $340M | Sell |
|
|||||
|
2022
Q4 | $368M | Buy |
|
|||||
|
2022
Q3 | $419M | Sell |
|
|||||
|
2022
Q2 | $362M | Sell |
|
|||||
|
2022
Q1 | $367M | Sell |
|
|||||
|
2021
Q4 | $315M | Buy |
|
|||||
|
2021
Q3 | $314M | Sell |
|
|||||
|
2021
Q2 | $396M | Buy |
|
|||||
|
2021
Q1 | $404M | Sell |
|
|||||
|
2020
Q4 | $512M | Buy |
|
|||||
|
2020
Q3 | $414M | Buy |
|
|||||
|
2020
Q2 | $486M | Sell |
|
|||||
|
2020
Q1 | $396M | Sell |
|
|||||
|
2019
Q4 | $509M | Buy |
|
|||||
|
2019
Q3 | $499M | Buy |
|
|||||
|
2019
Q2 | $511M | Buy |
|
|||||
|
2019
Q1 | $24.6M | Sell |
|
|||||
|
2018
Q4 | $20.7M | Buy |
|
|||||
|
2018
Q3 | $16M | Sell |
|
|||||
|
2018
Q2 | $13.4M | Buy |
|
|||||
|
2018
Q1 | $13.8M | Buy |
|
|||||
|
2017
Q4 | $12.9M | Sell |
|
|||||
|
2017
Q3 | $13.5M | Buy |
|
|||||
|
2017
Q2 | $11.4M | Buy |
|
|||||
|
2017
Q1 | $8.25M | Buy |
|
|||||
|
2016
Q4 | $4.35M | Sell |
|
|||||
|
2016
Q3 | $3.96M | Hold |
|
|||||
|
2016
Q2 | $2.52M | Sell |
|
|||||
|
2016
Q1 | $5.59M | Buy |
|